We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
AUDENZ (Seqirus Pty Ltd)
Product name
AUDENZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
212 (255 working days)
Active ingredients
Influenza virus haemagglutinin
Registration type
NCE/ NBE
Indication
AUDENZ is indicated for active immunisation against influenza A in persons from 6 months of age and older in an officially declared pandemic.